Aardvark Therapeutics annual meeting: directors elected, BDO ratified, option repricing approved

Aardvark Therapeutics, Inc.

Victor Tong Jr. and Jeffrey Chi elected as Class I directors; Tong received 6,264,929 votes for, Chi 6,426,038.
BDO USA ratified as independent auditor for FY2026 with 11,877,567 votes for.
Stock option repricing under 2017, 2025, and 2025 Inducement Plans approved with 4,649,269 for, 3,439,983 against.
Quorum of 54.79% of outstanding shares represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.